Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study.

Mauz-Körholz C, Landman-Parker J, Fernández-Teijeiro A, Attarbaschi A, Balwierz W, Bartelt JM, Beishuizen A, Boudjemaa S, Cepelova M, Ceppi F, Claviez A, Daw S, Dieckmann K, Fosså A, Gattenlöhner S, Georgi T, Hjalgrim LL, Hraskova A, Karlén J, Kurch L, Leblanc T, Mann G, Montravers F, Pears J, Pelz T, Rajić V, Ramsay AD, Stoevesandt D, Uyttebroeck A, Vordermark D, Körholz D, Hasenclever D, Wallace WH, Kluge R.

Open source

DOI: 10.1016/s1470-2045(23)00019-0
Published: 2023-03-01
Container: Lancet Oncol
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1470-2045-23-00019-0,
  title = {Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study.},
  author = {Mauz-Körholz C and  Landman-Parker J and  Fernández-Teijeiro A and  Attarbaschi A and  Balwierz W and  Bartelt JM and  Beishuizen A and  Boudjemaa S and  Cepelova M and  Ceppi F and  Claviez A and  Daw S and  Dieckmann K and  Fosså A and  Gattenlöhner S and  Georgi T and  Hjalgrim LL and  Hraskova A and  Karlén J and  Kurch L and  Leblanc T and  Mann G and  Montravers F and  Pears J and  Pelz T and  Rajić V and  Ramsay AD and  Stoevesandt D and  Uyttebroeck A and  Vordermark D and  Körholz D and  Hasenclever D and  Wallace WH and  Kluge R.},
  year = {2023},
  journal = {Lancet Oncol},
  doi = {10.1016/s1470-2045(23)00019-0},
  url = {https://doi.org/10.1016/s1470-2045(23)00019-0}
}

RIS

TY  - JOUR
TI  - Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study.
AU  - Mauz-Körholz C
AU  -  Landman-Parker J
AU  -  Fernández-Teijeiro A
AU  -  Attarbaschi A
AU  -  Balwierz W
AU  -  Bartelt JM
AU  -  Beishuizen A
AU  -  Boudjemaa S
AU  -  Cepelova M
AU  -  Ceppi F
AU  -  Claviez A
AU  -  Daw S
AU  -  Dieckmann K
AU  -  Fosså A
AU  -  Gattenlöhner S
AU  -  Georgi T
AU  -  Hjalgrim LL
AU  -  Hraskova A
AU  -  Karlén J
AU  -  Kurch L
AU  -  Leblanc T
AU  -  Mann G
AU  -  Montravers F
AU  -  Pears J
AU  -  Pelz T
AU  -  Rajić V
AU  -  Ramsay AD
AU  -  Stoevesandt D
AU  -  Uyttebroeck A
AU  -  Vordermark D
AU  -  Körholz D
AU  -  Hasenclever D
AU  -  Wallace WH
AU  -  Kluge R.
PY  - 2023
JO  - Lancet Oncol
DO  - 10.1016/s1470-2045(23)00019-0
UR  - https://doi.org/10.1016/s1470-2045(23)00019-0
ER  -

APA

C, M., J, L., A, F., A, A., W, B., JM, B., A, B., S, B., M, C., F, C., A, C., S, D., K, D., A, F., S, G., T, G., LL, H., A, H., J, K., L, K., T, L., G, M., F, M., J, P., T, P., V, R., AD, R., D, S., A, U., D, V., D, K., D, H., WH, W., & R., K. (2023). Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study.. Lancet Oncol. https://doi.org/10.1016/s1470-2045(23)00019-0

Source records

europe-pmc · retrieved 2026-09-26T14:14:52.324Z